Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U. (2023). Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. Poster presented at 17th Vaccine Congress, Glasgow (Scotland).